300 related articles for article (PubMed ID: 9135855)
1. Nacystelyn, a novel lysine salt of N-acetylcysteine, to augment cellular antioxidant defence in vitro.
Gillissen A; Jaworska M; Orth M; Coffiner M; Maes P; App EM; Cantin AM; Schultze-Werninghaus G
Respir Med; 1997 Mar; 91(3):159-68. PubMed ID: 9135855
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant function of ambroxol in mononuclear and polymorphonuclear cells in vitro.
Gillissen A; Bartling A; Schoen S; Schultze-Werninghaus G
Lung; 1997; 175(4):235-42. PubMed ID: 9195551
[TBL] [Abstract][Full Text] [Related]
3. In vitro comparative assessment of the antioxidant activity of nacystelyn against three reactive oxygen species.
Vanderbist F; Maes P; Nève J
Arzneimittelforschung; 1996 Aug; 46(8):783-8. PubMed ID: 9125279
[TBL] [Abstract][Full Text] [Related]
4. [N-acetylcysteine: a functional oxygen radical scavenger in vitro and ex vivo in monocytes and neutrophilic granulocytes of patients with COPD].
Jaworska M; Gillissen A; Schärling B; Wickenburg D; Schultze-Werninghaus G
Pneumologie; 1995 Oct; 49(10):539-45. PubMed ID: 8584524
[TBL] [Abstract][Full Text] [Related]
5. Oxidant scavenger function of ambroxol in vitro: a comparison with N-acetylcysteine.
Gillissen A; Schärling B; Jaworska M; Bartling A; Rasche K; Schultze-Werninghaus G
Res Exp Med (Berl); 1997; 196(6):389-98. PubMed ID: 9089888
[TBL] [Abstract][Full Text] [Related]
6. Nacystelyn inhibits oxidant-mediated interleukin-8 expression and NF-kappaB nuclear binding in alveolar epithelial cells.
Antonicelli F; Parmentier M; Drost EM; Hirani N; Rahman I; Donaldson K; MacNee W
Free Radic Biol Med; 2002 Mar; 32(6):492-502. PubMed ID: 11958950
[TBL] [Abstract][Full Text] [Related]
7. Effect of the mucoactive drug nacystelyn on the respiratory burst of human blood polymorphonuclear neutrophils.
Nagy AM; Vanderbist F; Parij N; Maes P; Fondu P; Nève J
Pulm Pharmacol Ther; 1997; 10(5-6):287-92. PubMed ID: 9778492
[TBL] [Abstract][Full Text] [Related]
8. Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease.
Kasielski M; Nowak D
Respir Med; 2001 Jun; 95(6):448-56. PubMed ID: 11421501
[TBL] [Abstract][Full Text] [Related]
9. Regulation of LPS-mediated inflammation in vivo and in vitro by the thiol antioxidant Nacystelyn.
Antonicelli F; Brown D; Parmentier M; Drost EM; Hirani N; Rahman I; Donaldson K; MacNee W
Am J Physiol Lung Cell Mol Physiol; 2004 Jun; 286(6):L1319-27. PubMed ID: 15136298
[TBL] [Abstract][Full Text] [Related]
10. Human neutrophil oxidative bursts and their in vitro modulation by different N-acetylcysteine concentrations.
Allegra L; Dal Sasso M; Bovio C; Massoni C; Fonti E; Braga PC
Arzneimittelforschung; 2002; 52(9):669-76. PubMed ID: 12404881
[TBL] [Abstract][Full Text] [Related]
11. Beta-2-agonists have antioxidant function in vitro. 2. The effect of beta-2-agonists on oxidant-mediated cytotoxicity and on superoxide anion generated by human polymorphonuclear leukocytes.
Gillissen A; Wickenburg D; van Zwoll D; Schultze-Werninghaus G
Respiration; 1997; 64(1):23-8. PubMed ID: 9044471
[TBL] [Abstract][Full Text] [Related]
12. Glutathione precursor and antioxidant activities of N-acetylcysteine and oxothiazolidine carboxylate compared in in vitro studies of HIV replication.
Raju PA; Herzenberg LA; Herzenberg LA; Roederer M
AIDS Res Hum Retroviruses; 1994 Aug; 10(8):961-7. PubMed ID: 7811547
[TBL] [Abstract][Full Text] [Related]
13. Decrease in gamma-glutamyltransferase activity in rat type II cells exposed in vitro to hyperoxia: effects of the 21-aminosteroid U-74389G.
van Klaveren RJ; Pype JL; Demedts M; Nemery B
Exp Lung Res; 1997; 23(4):347-59. PubMed ID: 9202959
[TBL] [Abstract][Full Text] [Related]
14. Lack of effect of N-acetylcysteine on the release of oxygen radicals from neutrophils and alveolar macrophages.
Drost E; Lannan S; Bridgeman MM; Brown D; Selby C; Donaldson K; MacNee W
Eur Respir J; 1991 Jun; 4(6):723-9. PubMed ID: 1889500
[TBL] [Abstract][Full Text] [Related]
15. Comparison of in vitro effects of two thiol-containing drugs on human neutrophils hydrogen peroxide production.
Gressier B; Cabanis A; Lebegue S; Brunet C; Dine T; Luyckx M; Cazin M; Cazin JC
Methods Find Exp Clin Pharmacol; 1993 Mar; 15(2):101-5. PubMed ID: 8487592
[TBL] [Abstract][Full Text] [Related]
16. The effect of N-acetylcysteine on ifosfamide-induced nephrotoxicity: in vitro studies in renal tubular cells.
Chen N; Aleksa K; Woodland C; Rieder M; Koren G
Transl Res; 2007 Jul; 150(1):51-7. PubMed ID: 17585863
[TBL] [Abstract][Full Text] [Related]
17. Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits.
Rushworth GF; Megson IL
Pharmacol Ther; 2014 Feb; 141(2):150-9. PubMed ID: 24080471
[TBL] [Abstract][Full Text] [Related]
18. [Antioxidant treatment with N-acetylcysteine and vitamin C in patients with chronic bronchitis].
Lukas R; Schärling B; Schultze-Werninghaus G; Gillissen A
Dtsch Med Wochenschr; 2005 Mar; 130(11):563-7. PubMed ID: 15761783
[TBL] [Abstract][Full Text] [Related]
19. Thiol-containing molecules interact with the myeloperoxidase/H2O2/chloride system to inhibit LDL oxidation.
Van Antwerpen P; Boudjeltia KZ; Babar S; Legssyer I; Moreau P; Moguilevsky N; Vanhaeverbeek M; Ducobu J; Nève J
Biochem Biophys Res Commun; 2005 Nov; 337(1):82-8. PubMed ID: 16171780
[TBL] [Abstract][Full Text] [Related]
20. A comparison of a new mucolytic N-acetylcysteine L-lysinate with N-acetylcysteine: airway epithelial function and mucus changes in dog.
Tomkiewicz RP; App EM; De Sanctis GT; Coffiner M; Maes P; Rubin BK; King M
Pulm Pharmacol; 1995 Dec; 8(6):259-65. PubMed ID: 8819180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
